Business ❯ Pharmaceutical Industry

Drug Manufacturing

Pricing Strategies Quality Control Investment Market Competition Regulatory Compliance Generic Drugs Investment Strategies Supply Chain Management Cost Management Market Dynamics

Supreme Court Rejects Drugmakers’ Appeals Over Medicare Price Talks

The move preserves rulings that back the Inflation Reduction Act program, letting new rounds of negotiated discounts proceed.

White House Projects $529 Billion in Savings From Trump’s MFN Drug Pricing Plan

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

Canada Approves First Generic Ozempic, Clearing Dr. Reddy’s Semaglutide

Pakistan Approves Prices for 35 Essential Drugs to Ease Shortages

Trump Seals Regeneron Drug-Pricing Pact, Completing 17-Company Push

Gurugram Bust Seizes 242 Suspected Fake Mounjaro Pens, Two Arrested

South Africa Receives First Lenacapavir Doses for Twice‑Yearly HIV Prevention

Anvisa Seizes Suspect Mounjaro Lots, Bans Unregistered Tirzec in Brazil

Pakistan Drug Regulator Denies Fresh Hikes for Essential Medicines

Delhi Court Pauses DRL’s ‘Olymviq’ Rollout in Ozempic Trademark Fight

Telangana Regulator Warns Against Unsupervised Semaglutide Use

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

UK Orders Recall of One Ramipril Batch After Amlodipine Found in Packs

Zentiva Recalls Ibuflam 600 mg Batch After Metal Fragment Found in Tablet

India Readies Dozens of Semaglutide Generics as Ozempic Patent Nears Expiry

Indian National Sentenced to 43 Months for Counterfeit Keytruda Scheme

TrumpRX.gov Launches With 40+ Lower-Priced Drugs as Companies Announce Cuts

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions